We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Summit Therapeutics Plc | LSE:SUMM | London | Ordinary Share | GB00BN40HZ01 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 20.50 | 18.00 | 23.00 | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMSUMM TR-1: Standard form for notification of major holdings 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached(ii) : SUMMIT THERAPEUTICS PLC 1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate) Non-UK issuer 2. Reason for the notification (please mark the appropriate box or boxes with an "X") An acquisition or disposal of voting rights X An acquisition or disposal of financial instruments An event changing the breakdown of voting rights X Other (please specify)(iii) : 3. Details of person subject to the notification obligation(iv) Name CANACCORD GENUITY GROUP INC City and country of registered office (if applicable) VANCOUVER, CANADA 4. Full name of shareholder(s) (if different from 3.)(v) Name DISCRETIONARY CLIENTS City and country of registered office (if applicable) As above 5. Date on which the threshold was crossed or reached(vi) : 29 MARCH 2018 6. Date on which issuer notified (DD/MM/YYYY): 02 JULY 2018 7. Total positions of person(s) subject to the notification obligation Total number of voting % of voting rights attached to shares (total of 8. % of voting rights through financial instruments Total of both in rights of A) (total of 8.B 1 + 8.B 2) % (8.A + 8.B) issuer(vii) Resulting situation on the date on which threshold was crossed or reached 6.7647 6.7647 81,901,173 Position of previous notification (if applicable) 4.1548 4.1548 8. Notified details of the resulting situation on the date on which the threshold was crossed or reached(viii) A: Voting rights attached to shares Class/type of shares ISIN code (if possible) Number of voting rights(ix) % of voting rights Direct Indirect Direct Indirect (Art 9 of Directive 2004/109/EC) (DTR5.1) (Art 10 of Directive 2004/109/EC) (DTR5.2.1) (Art 9 of Directive 2004/109/EC) (DTR5.1) (Art 10 of Directive 2004/109/EC) (DTR5.2.1) GB00BN40HZ01 N/A 5,540,382 N/A 6.7647 SUBTOTAL 8. A 5,540,382 6.7647 B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a)) Type of Expiration Exercise/ Number of voting rights that may be acquired if the % of financial date(x) Conversion Period(xi) instrument is voting instrument exercised/converted. rights SUBTOTAL 8. B 1 B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b)) Type of Expiration Exercise/ Physical or cash Number of voting rights % of financial date(x) Conversion Period (xi) settlement(xii) voting instrument rights SUBTOTAL 8.B.2 9. Information in relation to the person subject to the notification obligation (please mark the applicable box with an "X") Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer(xiii) Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entity(xiv) (please add additional rows as necessary) X % of voting rights if it equals or is higher than % of voting rights through financial instruments if Total of both if it equals or is higher than the notifiable Name(xv) the notifiable threshold it equals or is higher than the notifiable threshold threshold Canaccord Genuity Group Inc. 6.7647 6.7647 Canaccord Genuity Wealth Group Holdings Limited 6.7647 6.7647 Canaccord Genuity Wealth Group Holdings (Jersey) Limited 6.7647 6.7647 Hargreave Hale Ltd 6.7647 6.7647 10. In case of proxy voting, please identify: Name of the proxy holder The number and % of voting rights held The date until which the voting rights will be held 11. Additional information(xvi) The change in the percentage of shares held is due entirely to participation in the placing by Summit Therapeutics plc, the shares from which were admitted to AIM on 29/03/2018. Place of completion BLACKPOOL, ENGLAND Date of completion 02 JULY 2018 This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients. The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein. Source: Summit Therapeutics plc via Globenewswire http://www.summitplc.com/
(END) Dow Jones Newswires
July 02, 2018 12:47 ET (16:47 GMT)
Copyright (c) 2018 Dow Jones & Company, Inc.
1 Year Summit Therapeutics Chart |
1 Month Summit Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions